LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH M impact Sep 28, 2026, 10:00 AM UTC

FTAI acquires 27 Boeing 737-700 aircraft from WestJet

FTAI said it acquired 27 Boeing 737-700 aircraft from WestJet.

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

FTAI

Related stories

Meta Stock Drops Again. What Happened to Its Muse Boost? — Barrons.com By Callum KeownMeta stock was falling to start the week and is in danger of posting back-to-back losses for the first time since mid-August.The move comes amid broader pressure on L impact | EQUITY | Sep 28, 2026, 10:53 AM UTC Goldman says S&P 500 breadth at dot-com-era low Goldman Sachs says AI stocks are masking weakness beneath the S&P 500, with market breadth at its lowest since the dot-com bubble. The bank said the median S&P 500 stock trades 16% M impact | EQUITY | Sep 28, 2026, 10:52 AM UTC Cantor Fitzgerald maintains Underweight rating on Paychex, $96 price target Cantor Fitzgerald maintained their Underweight rating on Paychex's stock with a price target of $96.00.The price target implies a downside of 5.3% from the Sep 25 close of $101.37. L impact | EQUITY | Sep 28, 2026, 10:51 AM UTC Adicet Bio reports positive safety, efficacy data from prula-cel lupus study The company said prula-cel was well tolerated, with no CRS above grade 2 and no IEC-HS or ICANS. It plans pivotal lupus nephritis trial start-up activities in Q4 2026 and expects a M impact | EQUITY | Sep 28, 2026, 10:50 AM UTC Mirum rises 2.8% after FDA approves Atebrioz for rare bone disorder The approval was based on a 63-patient study; Mirum expects to launch the drug in October. L impact | EQUITY | Sep 28, 2026, 10:46 AM UTC Adicet Bio says prula-cel Phase 1 lupus study shows 54% DORIS remission at 12 months Company says patients also showed sustained disease control, broad discontinuation of immunosuppressants and steroid tapering. M impact | EQUITY | Sep 28, 2026, 10:46 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.